CompletedPhase 2NCT00219401
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
Studying Pneumococcal meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Papua New Guinea Institute of Medical Research
- Principal Investigator
- Peter Siba, PhDPapua New Guinea Institute of Medical Research
- Intervention
- Pneumococcal 7 valent conjugate vaccine (Prevenar®)(biological)
- Enrollment
- 318 target
- Eligibility
- All sexes
- Timeline
- 2005 – 2010
Study locations (1)
- Papua New Guinea Institute of Medical Research, Goroka, EHP, Papua New Guinea
Collaborators
The University of Western Australia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00219401 on ClinicalTrials.govOther trials for Pneumococcal meningitis
Additional recruiting or active studies for the same condition.